Company / PP&E (Net)
Glaukos Corp. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$113.3M
FY2025
5-year range
$69.0M / $113.3M
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#83 of 135
Health Care
What the data says
At $113M, Glaukos Corp.'s pp&e (net) ranks #83 of 135 in the Health Care sector. Improved from $103M to $113M over the past 2 years.
Based on SEC 10-K filings.
$113M in FY2025 with a 5-year CAGR of +36.4%.
Improved from $103M to $113M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +36.4%
- 10-Year CAGR
- -
Sector benchmark
#83 of 135 in Health CareTop 61% of 135This company $113.3M Sector average $1.4B
▼
-91.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +36.4%, indicating consistent growth.
- In FY2025, pp&e (net) increased 15.7% year-over-year.
- Ranks #83 out of 135 companies in the Health Care sector.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.3M | +15.7% |
| FY2024 | $97.9M | -5.2% |
| FY2023 | $103.2M | +9.3% |
| FY2022 | $94.4M | +36.9% |
| FY2021 | $69.0M | +187.3% |
| FY2020 | $24.0M | +8.9% |
| FY2019 | $22.1M | +15.2% |
| FY2018 | $19.2M | +62.4% |
| FY2017 | $11.8M | +55.3% |
| FY2016 | $7.6M | +252.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026